|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 5/077 | |
| C12N 5/0775 | |||
| A61K 35/35 | |||
| A61K 35/28 | |||
| A61P 17/00 | |||
| A61P 37/00 | |||
| A61P 43/00 |
| (11) | Patento numeris | 3046417 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14845486.1 |
| Europos patento paraiškos padavimo data | 2014-09-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-07-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-07-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/056145 |
| Data | 2014-09-17 |
| (87) | Numeris | WO 2015/042182 |
| Data | 2015-03-26 |
| (30) | Numeris | Data | Šalis |
| 201361880086 P | 2013-09-19 | US | |
| 201461977466 P | 2014-04-09 | US |
| (72) |
FRASER, John, US
MAGALON, Guy, US
|
| (73) |
Cytori Therapeutics, Inc.,
3020 Callan Road, San Diego, California 92121,
US
|
| (54) | METHODS OF USING ADIPOSE TISSUE-DERIVED CELLS IN THE TREATMENT OF RAYNAUD`S PHENOMENON ASSOCIATED WITH SCLERODERMA |
| METHODS OF USING ADIPOSE TISSUE-DERIVED CELLS IN THE TREATMENT OF RAYNAUD`S PHENOMENON ASSOCIATED WITH SCLERODERMA |